Related Experiment Video
Updated: Oct 23, 2025

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris
Daniel Zamith-Miranda1,2, Heino M Heyman3, Sneha P Couvillion3
1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Abstract:
Candida auris is a recently described multidrug-resistant pathogenic fungus that is increasingly responsible for health care-associated outbreaks across the world. Bloodstream infections of this fungus cause death in up to 70% of cases. Aggravating this scenario, the disease-promoting mechanisms of C. auris are poorly understood. Fungi release extracellular vesicles (EVs) that carry a broad range of molecules, including proteins, lipids, carbohydrates, pigments, and RNA, many of which are virulence factors. Here, we carried out a comparative molecular characterization of C. auris and Candida albicans EVs and evaluated their capacity to modulate effector mechanisms of host immune defense. Using proteomics, lipidomics, and transcriptomics, we found that C. auris released EVs with payloads that were significantly different from those of EVs released by C. albicans. EVs released by C. auris potentiated the adhesion of this yeast to an epithelial cell monolayer, while EVs from C. albicans had no effect. C. albicans EVs primed macrophages for enhanced intracellular yeast killing, whereas C. auris EVs promoted survival of the fungal cells. Moreover, EVs from both C. auris and C. albicans induced the activation of bone marrow-derived dendritic cells. Together, our findings show distinct profiles and properties of EVs released by C. auris and by C. albicans and highlight the potential contribution of C. auris EVs to the pathogenesis of this emerging pathogen. IMPORTANCE Candida auris is a recently described multidrug-resistant pathogenic fungus that is responsible for outbreaks across the globe, particularly in the context of nosocomial infections. Its virulence factors and pathogenesis are poorly understood. Here, we tested the hypothesis that extracellular vesicles (EVs) released by C. auris are a disease-promoting factor. We describe the production of EVs by C. auris and compare their biological activities against those of the better-characterized EVs from C. albicans. C. auris EVs have immunoregulatory properties, of which some are opposite those of C. albicans EVs. We also explored the cargo and structural components of those vesicles and found that they are remarkably distinct compared to EVs from C. auris's phylogenetic relative Candida albicans.
Insights
Extracellular vesicles (EVs) from Candida auris, a dangerous multidrug-resistant fungus, differ from Candida albicans EVs. C. auris EVs promote fungal survival and adhesion, contributing to its pathogenesis.
Area of Science:
- Mycology
- Immunology
- Pathogenesis Research
Background:
- Candida auris is an emerging multidrug-resistant fungal pathogen causing global health care-associated outbreaks.
- Its disease mechanisms and virulence factors remain poorly understood.
- Fungal extracellular vesicles (EVs) are implicated as virulence factors.
Purpose of the Study:
- To comparatively characterize Candida auris and Candida albicans EVs.
- To evaluate the capacity of these EVs to modulate host immune defense mechanisms.
- To investigate the role of C. auris EVs in fungal pathogenesis.
Main Methods:
- Proteomics, lipidomics, and transcriptomics for molecular characterization of EVs.
- Assays to evaluate EV effects on yeast adhesion to epithelial cells.
- Macrophage and dendritic cell activation assays to assess immune response modulation.
Main Results:
- Candida auris EVs exhibit distinct molecular payloads compared to Candida albicans EVs.
- C. auris EVs enhance yeast adhesion to epithelial cells and promote fungal survival in macrophages.
- EVs from both species activate bone marrow-derived dendritic cells, but C. auris EVs have unique immunomodulatory properties.
Conclusions:
- Candida auris EVs possess distinct profiles and properties compared to Candida albicans EVs.
- These C. auris EVs contribute to the pathogenesis of this emerging fungal pathogen.
- Understanding C. auris EV function is crucial for developing targeted therapeutic strategies.

